View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
Nivolumab 1 / Ipilimumab 3, Bladder Cancer, Cycle 5-8
Protocol-ID: 2695 V1.0 (Mini), NIVO1/IPIL3, Bladder Cancer, C5-8Indication(s)
- Bladder Cancer; ICD-10 C67.-
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti. |
Valid since: 23.08.2024